Profitelligence Profitelligence · Filing Ledger Open TMO research →

Form 8-K · Current Report · Filed 2025-05-22

Thermo Fisher Scientific Approves Long-Term Incentive Award for CEO

On May 21, 2025, Thermo Fisher Scientific Inc.'s Board of Directors approved a 5-year cliff vesting performance-based restricted stock units for its CEO, Marc N.

Filer
Thermo Fisher Scientific Inc. TMO · NYSE
Filed
Accession
0000097745-25-000066
CIK
0000097745
Signal
High impactHealthcare

Details

Casper, to secure his leadership through at least May 2030 and drive substantial returns to shareholders. The award, valued at approximately $60 million, is designed to incentivize total shareholder return (TSR) outperformance and aligns with market compensation practices.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CEO Resignation New CEO Appointed Executive Compensation Detail
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$398.28

Next session

-1.2%

Since filing

+44.2%

Latest close

$574.30

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TMO reporting the same item, with the next session's move:

Exhibits (1)

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another TMO filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts